Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas
Clinical trial NCT02978261 · COMPLETED
Trial details
- NCT number
- NCT02978261
- Sponsor
- Beijing Pearl Biotechnology Limited Liability Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.